Author:
Lowery Robert G.,Kumar Meera
Reference9 articles.
1. Zielinski T, Kimple AJ, Hutsell SQ, Koeff MD, Siderovski DP, Lowery RG (2009) Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity. J Biomol Screen 14:1195–1206
2. Reichman M, Schabdach A, Kumar M, Zielinski T, Donover PS, Laury-Kleintop LD, Lowery RG (2015) A high-throughput assay for rho guanine nucleotide exchange factors based on the Transcreener GDP assay. J Biomol Screen 20:1294–1299
3. Hall MD, Yasgar A, Peryea T, Braisted JC, Jadhav A, Simeonov A, Coussens NP (2016) Fluorescence polarization assays in high-throughput screening and drug discovery: a review. Methods Appl Fluoresc 4:022001
4. Vedvik KL, Eliason HC, Hoffman RL, Gibson JR, Kupcho KR, Somberg RL, Vogel KW (2004) Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracers. Assay Drug Dev Technol 2:193–203
5. Bosch DE, Zielinski T, Lowery RG, Siderovski DP (2012) Evaluating modulators of “regulator of G-protein signaling” (RGS) proteins. Curr Protoc Pharmacol Chapter 2(Unit2):8